Oppenheimer & Co’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-131
| Closed | -$1.74K | – | 1481 |
|
2023
Q2 | $1.74K | Hold |
131
| – | – | ﹤0.01% | 1411 |
|
2023
Q1 | $10.2K | Hold |
131
| – | – | ﹤0.01% | 1374 |
|
2022
Q4 | $10.9K | Hold |
131
| – | – | ﹤0.01% | 1343 |
|
2022
Q3 | $12K | Hold |
131
| – | – | ﹤0.01% | 1353 |
|
2022
Q2 | $20K | Hold |
131
| – | – | ﹤0.01% | 1387 |
|
2022
Q1 | $32K | Buy |
+131
| New | +$32K | ﹤0.01% | 1450 |
|
2021
Q3 | – | Sell |
-153
| Closed | -$47K | – | 1592 |
|
2021
Q2 | $47K | Sell |
153
-85
| -36% | -$26.1K | ﹤0.01% | 1488 |
|
2021
Q1 | $49K | Hold |
238
| – | – | ﹤0.01% | 1419 |
|
2020
Q4 | $48K | Sell |
238
-62
| -21% | -$12.5K | ﹤0.01% | 1330 |
|
2020
Q3 | $50K | Sell |
300
-10
| -3% | -$1.67K | ﹤0.01% | 1260 |
|
2020
Q2 | $77K | Sell |
310
-61
| -16% | -$15.2K | ﹤0.01% | 1217 |
|
2020
Q1 | $67K | Buy |
371
+62
| +20% | +$11.2K | ﹤0.01% | 1144 |
|
2019
Q4 | $89K | Buy |
+309
| New | +$89K | ﹤0.01% | 1246 |
|
2017
Q1 | – | Sell |
-206
| Closed | -$23K | – | 1358 |
|
2016
Q4 | $23K | Buy |
206
+18
| +10% | +$2.01K | ﹤0.01% | 1266 |
|
2016
Q3 | $27K | Hold |
188
| – | – | ﹤0.01% | 1251 |
|
2016
Q2 | $24K | Sell |
188
-558
| -75% | -$71.2K | ﹤0.01% | 1207 |
|
2016
Q1 | $113K | Buy |
746
+558
| +297% | +$84.5K | ﹤0.01% | 1170 |
|
2015
Q4 | $34K | Buy |
188
+63
| +50% | +$11.4K | ﹤0.01% | 1253 |
|
2015
Q3 | $18K | Buy |
+125
| New | +$18K | ﹤0.01% | 1333 |
|